MS: Busting the Myths
June 14, 2021 | Advocacy, Treatments, Trials
About 10% of people with MS are diagnosed with Primary Progressive Multiple Sclerosis (PPMS). While more common forms of MS involve a relapse-remit pattern (unpredictable attacks followed by periods of disease inactivity), PPMS is characterised by a slow onset and […]
June 3, 2021 | Advocacy, Covid-19, Event, Treatments, Uncategorised
Understandably, there is a high level of interest within the Multiple Sclerosis (MS) Community for information about how the Pfizer vaccine works and is impacting people with MS globally. Due to this Multiple Sclerosis New Zealand and the Ministry of […]
May 20, 2021 | Advocacy, Media, Treatments
Anne Beasley had to travel to India for Hematopoietic Stem Cell Transplant (HSCT) at the end of 2019 and at a cost of $42,000 Although it is already available in New Zealand for people with blood and bone marrow cancer, […]
April 9, 2021 | Advocacy, Education, Event, Life with MS, Treatments
Media Release – For Immediate Release 8 April 2021 Personal ‘Bangers to Bluff’ Crusade to Keep MS Patients Wheelchair-free For most, the annual Rotary Club of Half Moon Bay ‘Bangers to Bluff’ event is a chance to drive from […]
April 9, 2021 | Advocacy, Life with MS, Treatments
At the November 2020 meeting of PHARMAC’s Pharmacology and Therapeutics Advisory Committee (PTAC) further information was reviewed to support the application for funding of Ocrelizumab for Primary Progressive MS. At this meeting PTAC recommended listing with low priority and have requested […]